Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp

Bullboard Posts

Comment by 55orbuston Dec 17, 2018 2:53pm

55 Views

Post# 29125362

RE:RE:Waiting for Sub $40 and Then Incredible 2019

You can hear Bruce say it in this interview. Start listening at 1:04:45 https://youtu.be/WU0Qhjdy2nc

pungentaroma wrote: Cany you show a limnk to this comment
5. Edibles/CBD and THC infused drinks in Canada. 197,000 square foot bottling plant in Smiths Falls to be completed around mid-2019

I've searched for the link that shows a 197,000 sq ft bottling facility. I'd be thrilled if it were true but want to confirm this before repeating it.
TNY is in Cali and building out a 20,000 sq ft bottling facility to market THC-infused, liquor inspired beverages. Cali is the bggest beverage market in thNorth America so The number you report sounds crazy for the Canadian market. Saying that, I hope it is true.

Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.weed&postid=29124558#wWpizWJyZ455u5A6.99

ledzep4u wrote: Waiting for under $40 for my second round of buying to fully fill my non-core trading position. I believe this could be one of the last opportunities to do so given what's going to happen in 2019:

1. US hemp federally legal (will be a large number of announcements from the Canopy/Constellation partnership)

2. Germany will announce results of RFP to provide medical early in new year. Canopy is the biggest player there and well positioned with established production and distribution channels

3. Mexico to legalize (has 3.5X Canada's population) and I see Canopy as a large player. Constellation already has large presence in Mexico (200 rail cars/day of Corona from Mexico to USA for distribution)

4. UK will move forward with wider use of medical (Canopy has presence already)

5. Edibles/CBD and THC infused drinks in Canada. 197,000 square foot bottling plant in Smiths Falls to be completed around mid-2019

6. 30 Countries legal/going legal or persuing feasibility of going legal. If South Korea can go legal medical then any other country in the world can also do it

7. The USA will legalize medical and even rec. (not "if", but "when")

8. $5 billion in cash to do all of the above.